《癌癥管理與研究》是一份國際、同行評議、開放獲取的期刊，專注于癌癥研究和最佳使用預(yù)防和綜合治療干預(yù)措施，以改善癌癥患者的預(yù)后、提高生存率和生活質(zhì)量。雜志的專題包括:?流行病學(xué)，檢測和篩查?細(xì)胞研究和生物標(biāo)志物?識別具有新行動機(jī)制的生物目標(biāo)和制劑?優(yōu)化現(xiàn)有抗癌藥物的臨床應(yīng)用，包括聯(lián)合治療?放療和手術(shù)?姑息治療?患者依從性，生活質(zhì)量，滿意度?衛(wèi)生經(jīng)濟(jì)評估該雜志歡迎提交的論文，涵蓋原始研究，基礎(chǔ)科學(xué)，臨床和流行病學(xué)研究，審查和評估，指南，專家意見和評論，以及案例系列，對疾病或疾病亞型的新見解。除特殊情況外，該雜志不考慮個案報(bào)告。

Cancer Management and Research is an international, peer reviewed, open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for cancer patients. Specific topics covered in the journal include: ?Epidemiology, detection and screening?Cellular research and biomarkers?Identification of biotargets and agents with novel mechanisms of action?Optimal clinical use of existing anticancer agents, including combination therapies?Radiation and surgery?Palliative care?Patient adherence, quality of life, satisfaction?Health economic evaluations The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, and case series that shed novel insights on a disease or disease subtype. The journal does not consider case reports except in exceptional circumstances.